Oncogenic role of nuclear accumulated Aurora-A

Masaaki Tatsuka1, Sunao Sato, Akifumi Kanda

  • 1Department of Life Sciences, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, Hiroshima 727-0023, Japan.

Molecular Carcinogenesis
|February 11, 2009
PubMed

Insights

Nuclear accumulation of Aurora-A kinase is crucial for cancer transformation. This finding reveals a new nuclear function for Aurora-A in cancer, suggesting nuclear targets for therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Aurora-A kinase (Aik, BTAK, STK15) is a proto-oncogene overexpressed in many human cancers.
  • Mechanisms of Aurora-A overexpression include gene amplification, mRNA overexpression, and proteolytic resistance.
  • The role of Aurora-A overexpression in cancer cell transformation remains incompletely understood.

Purpose of the Study:

  • To investigate the role of Aurora-A localization in cancer cell transformation.
  • To determine the functional significance of nuclear versus centrosomal Aurora-A.
  • To identify novel therapeutic targets based on Aurora-A function in cancer.

Main Methods:

  • Cellular protein fractionation and immunoblot analysis to determine Aurora-A subcellular localization.
  • Indirect immunofluorescence using confocal laser microscopy to visualize Aurora-A in cancer cells and normal keratinocytes.
  • Functional assays involving expression of nuclear export signal-fused Aurora-A to assess transformation activity.

Main Results:

  • Nuclear accumulation of Aurora-A was observed in head and neck cancer cells, distinct from centrosomal localization in normal oral keratinocytes.
  • Disruption of nuclear localization by a nuclear export signal abolished Aurora-A's oncogenic transformation activity.
  • Previous findings of cytoplasmic Aurora-A via immunohistochemistry may not reflect its functional localization in intact cancer cells.

Conclusions:

  • Nuclear localization of Aurora-A is critical for its oncogenic transformation activity.
  • This study identifies a novel nuclear function of Aurora-A in cancer.
  • Substrates of nuclear Aurora-A represent potential novel therapeutic targets for cancer treatment.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...